Samuel DE SOUSA PEREIRA de Sousa Pereira Araujo

Mr. Samuel DE SOUSA PEREIRA de Sousa Pereira Araujo

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PSP S Santos
P S Santos
JJJ L Pereira Júnior
J L Pereira Júnior
SASamuel DE SOUSA PEREIRA de Sousa Pereira Araujo
Samuel DE SOUSA PEREIRA de Sousa Pereira Araujo
JSJ A da Silva
J A da Silva
ASA F M da Silva
A F M da Silva
JSJoão Paulo J Sabino
João Paulo J Sabino
This study aimed to evaluate the effects of the ketamine-xylazine (KX) anesthetic mixture on autonomic and cardiovascular functions in normotensive rats (Wistar) and spontaneously hypertensive rats (SHR), using both spectral and symbolic analyses. Male Wistar (n=22) and SHR (n=28) rats were intramuscularly anesthetized with KX, and their femoral artery and vein were cannulated for pulsatile arterial pressure recording and drug administration. Autonomic function was assessed 24 and 48 h post-surgery through spectral and symbolic analyses of heart rate (HR) and systolic arterial pressure (SAP) variability. KX anesthesia significantly decreased mean arterial pressure (MAP) 24 h post-surgery in both Wistar and SHR rats. Spectral analysis revealed increased sympathetic modulation in the vascular bed of SHR 48 h post-surgery. In Wistar rats, there was a significant reduction in parasympathetic modulation at 48 h, as indicated by root mean square of successive RR interval differences (RMSSD) and high frequency (HF) (nu) indices. Symbolic analysis, however, detected no significant changes in autonomic modulation. These data are consistent with the notion that KX anesthesia significantly impacts autonomic and cardiovascular functions, with differential effects observed between Wistar and SHR rats. Spectral analysis proved more effective than symbolic analysis in detecting these changes. These findings highlight the need for careful consideration of anesthetic effects in experimental research and suggest that optimizing anesthetic protocols could improve clinical outcomes by minimizing adverse autonomic impact.

18 December 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
FBFernando Sabath de Oliveira Bernardes
Fernando Sabath de Oliveira Bernardes
EREloisa Maria Gatti Regueiro
Eloisa Maria Gatti Regueiro
RBreinaldo Bulgarelli bestetti
reinaldo Bulgarelli bestetti
SASamuel DE SOUSA PEREIRA de Sousa Pereira Araujo
Samuel DE SOUSA PEREIRA de Sousa Pereira Araujo
JSJoão Paulo J Sabino
João Paulo J Sabino
MDMarina de Toledo Durand
Marina de Toledo Durand
Conventional and electronic cigarette (e-cig) users face an increased risk of cardiorespiratory diseases, driven by well-characterized pathways involving inflammation and oxidative stress (OS). Conventional cigarettes contain numerous harmful chemicals, such as nicotine and non-nicotine compounds, which produce reactive oxygen species. Although initially considered a safer alternative, the e-cig still generates toxic aldehydes that are capable of triggering oxidative responses. Heart rate variability (HRV) is an important tool for assessing autonomic function and predicting prognosis. Cardiac autonomic dysfunction, indicated by reduced HRV, has emerged as a critical cardiovascular risk factor associated with several diseases. Clinical and experimental studies show that increased OS is directly associated with heightened sympathetic activity and inversely with parasympathetic modulation. This review demonstrates that exposure to conventional cigarettes smoking and e-cigs adversely affects cardiac autonomic function, detectable by a global reduction in HRV that reflects a shift toward sympathetic dominance and a consequent increase in cardiovascular risk. These changes are associated with increased OS due to nicotine and non-nicotine compounds maintaining sympathovagal imbalance in smokers. Thus, we suggest that autonomic dysfunction, detected by HRV, correlates with oxidative responses and may be used as a modifiable risk factor in longitudinal studies involving both smoking modalities.

1 October 2025 in Medicina (Ribeirão Preto)
Verified
Journal Article
Open access
PDF file
JJJosé Lopes Pereira Júnior
José Lopes Pereira Júnior
SASamuel DE SOUSA PEREIRA de Sousa Pereira Araujo
Samuel DE SOUSA PEREIRA de Sousa Pereira Araujo
JSJuliana Alves da Silva
Juliana Alves da Silva
JAJosé Guilherme Veras de Assunção
José Guilherme Veras de Assunção
ASAna Flávia Moraes da Silva
Ana Flávia Moraes da Silva
JSJoão Paulo J Sabino
João Paulo J Sabino
Objective: Thus, the objective of this review was to survey secondary metabolites with hypotensive action and to highlight possible mechanisms of action. Methodology: The Cochrane Library, Science Direct, Lilacs, Web of Science, and PubMed databases were used with the help of the descriptors: “medicinal plants” OR “herbal medicine”, “volatile oils” OR “alkaloids” OR “diterpene alkaloids” OR “terpenes” OR “sesquiterpenes” OR “monoterpenes” OR “isoprenoids” OR “flavonoids” OR “tannins” OR “phenolic compounds” AND “antihypertensive agents”. The time frame was from 2012 to 2022, and articles were selected in Portuguese, Spanish, and English. The Rayyan platform was used to list references, remove duplicates, screen, and assess eligibility. Results: Of the 6,196 articles retrieved from databases and reference lists, 17 were included. The findings show that various secondary metabolites, such as essential oils, alkaloids, flavonoids, and phenols, present hypotensive activity through various mechanisms, such as blocking calcium channels, increasing the production of nitric oxide via eNOS, decreasing angiotensin-II, and blocking ganglionic receptors. Notably, many metabolites showed antioxidant activity, which may indirectly contribute to the hypotensive effect. The therapeutic potential of the compounds above is relevant since the mentioned effects were found in the main experimental models of AH, among which the following stand out: spontaneously hypertensive rats (SHR), which mimics human essential hypertension; L-NAME model that causes AH by systemic vasoconstriction due to reduction in nitric oxide synthesis; model using deoxycorticosterone (DOCA) which triggers AH due to sodium and water retention; model by administration of nicotine that induces an increase in oxidative stress, resulting in less endothelium-dependent vasodilation due to endothelial dysfunction. Conclusion: It is concluded that secondary metabolites with hypotensive effects can act through different mechanisms of action in different blood pressure control systems, thus becoming potent therapeutic targets, which can contribute to the development of new antihypertensive drugs on the market.